Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patient followed for metastatic prostate adenocarcinoma | patient wil be followed for metastatic prostate adenocarcinoma during 3 years |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Local chemotherapy | Drug | Local chemotherapy will be administrated according to local recommendation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of alive patient | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Number of alive patient disease free | 3 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with metastatic prostate adenocarcinoma resistant to castration
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christian PFISTER | University Hospital, Rouen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rouen University Hospital | Rouen | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided